Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 2,210,000 shares, a drop of 21.9% from the April 30th total of 2,830,000 shares. Based on an average trading volume of 1,010,000 […]
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) was the target of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 2,210,000 shares, a decrease of 21.9% from the April 30th total of 2,830,000 shares. Based on an average trading volume of 1,010,000 […]
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) insider Alexandra Hughes-Wilson sold 100,432 shares of Mereo BioPharma Group stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $2.97, for a total transaction of $298,283.04. Following the sale, the insider now owns 32,568 shares in […]
Cantor Fitzgerald reissued their overweight rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) in a research report released on Thursday morning, Benzinga reports. Cantor Fitzgerald currently has a $7.00 target price on the stock. Separately, Needham & Company LLC reaffirmed a buy rating and set a $6.00 price objective on shares of […]
Mereo BioPharma Group (NASDAQ:MREO – Get Free Report)‘s stock had its “overweight” rating restated by equities research analysts at Cantor Fitzgerald in a research report issued on Thursday, Benzinga reports. They presently have a $7.00 target price on the stock. Cantor Fitzgerald’s price objective would suggest a potential upside of 113.41% from the company’s current […]